What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history

Tuesday: An Insider’s experience at the iGEM Giant Boston Jamboree 2015

Wednesday: Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!

Thursday: The Future Biotech Lab Bench: My experience of the cutting edge-tech at LABVOLUTION

Friday: Alzheimer’s Disease: Phase III breakthrough Tau-therapy earns Scottish Biotech €120M

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.